These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2416198)

  • 21. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells.
    Borras-Cuesta F; Petit-Camurdan A; Fedon Y
    Eur J Immunol; 1987 Aug; 17(8):1213-5. PubMed ID: 2442000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein.
    Spitler L; Benjamini E; Young JD; Kaplan H; Fudenberg HH
    J Exp Med; 1970 Jan; 131(1):133-48. PubMed ID: 5409944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide.
    Milich DR; McLachlan A; Chisari FV; Thornton GB
    J Exp Med; 1986 Aug; 164(2):532-47. PubMed ID: 2425034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies reactive with specific amino acid sequences of the 126 K protein of tobacco mosaic virus.
    Das P; Hari V
    Arch Virol; 1994; 137(1-2):179-83. PubMed ID: 7526825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides.
    Fournier P; Ammerlaan W; Ziegler D; Giminez C; Rabourdin-Combe C; Fleckenstein BT; Wiesmüller KH; Jung G; Schneider F; Muller CP
    Int Immunol; 1996 Sep; 8(9):1441-51. PubMed ID: 8921422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limitations of different ELISA procedures for localizing epitopes in viral coat protein subunits.
    Dekker EL; Porta C; Van Regenmortel MH
    Arch Virol; 1989; 105(3-4):269-86. PubMed ID: 2473721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei.
    Romero PJ; Tam JP; Schlesinger D; Clavijo P; Gibson H; Barr PJ; Nussenzweig RS; Nussenzweig V; Zavala F
    Eur J Immunol; 1988 Dec; 18(12):1951-7. PubMed ID: 2464495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The T-lymphocyte response to varicella-zoster viral proteins.
    Arvin AM; Koropchak CM; Sharp M; Bergen R; Diaz PS
    Adv Exp Med Biol; 1990; 278():71-81. PubMed ID: 1963047
    [No Abstract]   [Full Text] [Related]  

  • 35. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
    Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
    J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constraints in T-B cooperation related to epitope topology on E. coli beta-galactosidase. I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants.
    Manca F; Kunkl A; Fenoglio D; Fowler A; Sercarz E; Celada F
    Eur J Immunol; 1985 Apr; 15(4):345-50. PubMed ID: 2580713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of lysozyme-specific immune responses by synthetic peptides. I. Characterization of antibody and T cell-mediated responses to the N-terminal peptide of hen egg-white lysozyme.
    Sette A; Colizzi V; Appella E; Doria G; Adorini L
    Eur J Immunol; 1986 Jan; 16(1):1-6. PubMed ID: 2936608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical studies of tobacco mosaic virus--V. Localization of four epitopes in the protein subunit by inhibition tests with synthetic peptides and cleavage peptides from three strains.
    Altschuh D; Hartman D; Reinbolt J; Van Regenmortel MH
    Mol Immunol; 1983 Mar; 20(3):271-8. PubMed ID: 6191202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.